NDUFC1

NADH dehydrogenase [ubiquinone] 1 subunit C1, · O43677 · NDUFC1 on Sugi Atlas →

3,247 patent compounds predicted against NDUFC1, 2,021 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Auraptene Auraptene (SCHEMBL2535029) 1.00 5/20
Auraptene Auraptene (SCHEMBL2535034) 1.00 5/20
SCHEMBL8491443 SCHEMBL8491443 0.56 4/20
SCHEMBL8489900 SCHEMBL8489900 0.52 4/20
SCHEMBL8489907 SCHEMBL8489907 0.52 4/20
SCHEMBL8489902 SCHEMBL8489902 0.51 4/20
SCHEMBL8489908 SCHEMBL8489908 0.51 4/20
SCHEMBL8491154 SCHEMBL8491154 0.51 4/20
SCHEMBL8491160 SCHEMBL8491160 0.51 4/20
SCHEMBL8491619 SCHEMBL8491619 0.50 4/20
SCHEMBL8491624 SCHEMBL8491624 0.50 4/20
SCHEMBL8491634 SCHEMBL8491634 0.50 4/20
7-Prenyloxycoumarin 7-Prenyloxycoumarin (SCHEMBL4898255) 0.79 3/20
SCHEMBL712741 SCHEMBL712741 0.57 3/20
Geiparvarin Geiparvarin (SCHEMBL2532495) 0.56 3/20
SCHEMBL6267768 SCHEMBL6267768 0.55 3/20
SCHEMBL1095981 SCHEMBL1095981 0.55 3/20
SCHEMBL4293165 SCHEMBL4293165 0.55 3/20
SCHEMBL8490928 SCHEMBL8490928 0.53 3/20
SCHEMBL8490937 SCHEMBL8490937 0.53 3/20

Clinical trials — most relevant to NDUFC1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease PHASE3COMPLETED
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder PHASE2WITHDRAWN
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy PHASE2ACTIVE_NOT_RECRUITING
Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease PHASE2COMPLETED
Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)? PHASE1UNKNOWN
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) nanRECRUITING
Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine nanCOMPLETED
The Natural History of Mitochondrial Diseases nanRECRUITING
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
Survey on Supplement Use in Mitochondrial Disease nanCOMPLETED
Diagnostic Odyssey Survey 2 nanCOMPLETED
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
Natural History in Primary Mitochondrial Myopathies nanRECRUITING
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases nanRECRUITING
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes nanNOT_YET_RECRUITING
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip nanCOMPLETED
Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection nanCOMPLETED
Nicotinamide Riboside and Mitochondrial Biogenesis nanCOMPLETED
Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability. nanUNKNOWN
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants nanRECRUITING
A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular Powerhouse) Dysfunction nanCOMPLETED
Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED
Calf Muscle Strength in Mitochondrial Diseases nanCOMPLETED
The Genetics of Diabetes in Southern California Chinese Americans nanWITHDRAWN
Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED
Ccf mtDNA as a Neurodegenerative Biomarker nanUNKNOWN
Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS nanRECRUITING
Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome nanCOMPLETED
Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a NDUFC1 binder may also engage these)

ProteinNameSimilarity
Q0MQF6 1.000 Q0MQF6 →
P0CB69 1.000 P0CB69 →
P0CB70 0.999 P0CB70 →
Q0MQF5 0.999 Q0MQF5 →
Q02376 0.994 Q02376 →
Q9CQY9 0.992 Q9CQY9 →
Q863G0 0.987 Q863G0 →
P60182 0.986 P60182 →
Q863G5 0.986 Q863G5 →
P60183 0.985 P60183 →
Q8SQ79 0.984 Q8SQ79 →
Q8SPI5 0.984 Q8SPI5 →
P10175 0.984 P10175 →
Q862Z9 0.984 Q862Z9 →
P60181 0.984 P60181 →
Q0MQC7 0.983 Q0MQC7 →
Q863G6 0.983 Q863G6 →
P80433 0.983 P80433 →
Q863G1 0.983 Q863G1 →
Q863G2 0.982 Q863G2 →
Q863G3 0.982 Q863G3 →
Q7JX57 0.981 Q7JX57 →
Q0MQJ3 0.981 Q0MQJ3 →
Q863F8 0.981 Q863F8 →
Q8TF08 0.980 Q8TF08 →
Q863F9 0.980 Q863F9 →
Q863G7 0.980 Q863G7 →
Q4R648 0.980 Q4R648 →
Q0MQC8 0.980 Q0MQC8 →
Q863G4 0.980 Q863G4 →